XML 39 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 18 - Stock Option and Purchase Plans
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
18
)        Stock Option and Purchase Plans
 
The Company
’s stock compensation program provides for the grant of restricted stock (including performance-based restricted stock), unrestricted stock, stock options and stock appreciation rights. A total of
3,655,088
shares of common stock were registered for issuance under the
2010
Omnibus Plan. On
May 19, 2015,
the
2010
Omnibus Plan was replaced with the
2015
Omnibus Plan. A total of
3,476,021
shares were registered for issuance under the
2015
Omnibus Plan. Additionally, awards under the
2010
Omnibus Plan that are cancelled without having been fully exercised or vested are available again for new awards under the
2015
Omnibus Plan. The aggregate number of shares available for future grant as of
December 
31,
 
2017
and
2016
was
1,314,021
and
1,712,021,
respectively.
 
The
2010
and
2015
Omnibus Plans provide for restrictions which lapse after
three
years. During the restricted period, which is commensurate with each vesting period, the recipient has the right to receive dividends and voting rights for the shares. Generally, if a recipient leaves the Company before the end of the restricted period or if performance requirements, if any, are
not
met, the shares will be forfeited.
 
Under the plans, t
he Company
may
grant options to purchase common stock to officers, key employees and non-employee directors. Options
may
be granted at
not
less than the market price on the date of grant. Stock option grants under the
2010
and
2015
Omnibus Plans include a
five
year life along with vesting after
three
years of service.
 
Compensation expense is measured based on the fair value at the date of grant and is recognized on a straight-line basis over the vesting period.
Fair value for restricted shares is equal to the stock price on the date of grant, while the fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing method. The Company uses historical Company and industry data to estimate the expected price volatility, the expected option life and the expected dividend yield. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option.
 
The following weighted average assumptions were used to estimate the fair value of options granted using the Black-Scholes option-pricing model:
 
   
Year ended December 31,
 
   
2017
   
2016
 
Expected life (years)
   
4.0
     
4.0
 
Expected volatility
   
51.2
%    
52.0
%
Risk-free interest rates
   
1.91
%    
1.42
%
Expected dividend yield
   
0.0
%    
0.0
%
 
A summary of the restricted
stock activity is as follows:
 
   
 
 
 
 
Weighted
 
   
 
 
 
 
Average
 
   
Number of
   
Grant Date
 
   
Shares
   
Fair Value
 
Nonvested shares at January 1, 2017
   
1,165,000
    $
1.49
 
Granted
   
199,000
     
1.06
 
Vested
   
(296,000
)    
2.26
 
Forfeited
   
(39,000
)    
1.15
 
Nonvested shares at December 31, 2017
   
1,029,000
    $
1.20
 
 
The total fair value of shares vested during
2017
and
2016
was
$408,000
and
$536,000,
respectively.
 
The following table summarizes option activity for the year ended
December 31,
2017:
 
   
 
 
 
 
Weighted-
   
Weighted-
   
 
 
 
   
 
 
 
 
average
   
average
   
Aggregate
 
   
Number of
   
Exercise Price
   
Remaining
   
Intrinsic
 
   
Shares
   
Per Share
   
Term
   
Value
 
Outstanding at January 1, 2017
   
1,908,250
    $
2.07
     
 
     
 
 
Granted
   
272,500
     
1.08
     
 
     
 
 
Exercised
   
0
     
0
     
 
     
 
 
Forfeited
   
(45,000
)    
1.16
     
 
     
 
 
Expired
   
(314,750
)    
3.49
     
 
     
 
 
Outstanding at December 31, 2017
   
1,821,000
    $
1.70
     
2.28
    $
444,000
 
Exercisable at December 31, 2017
   
523,200
    $
2.99
     
0.99
    $
34,000
 
 
The weighted average grant date fair value based on the Black-Scholes option pricing model for options granted in the year
s ended
December 
31,
 
2017
and
2016
was
$0.45
and
$0.38
per share, respectively. There were
no
options exercised in
2017
or
2016.
 
As of
December
 
31,
 
2017,
there was
$746,000
of total unrecognized compensation cost related to unvested share-based compensation granted under the plans. That cost is expected to be recognized over a weighted-average period of
1.1
years. The total fair value of option shares vested during the years ended
December 
31,
 
2017
and
2016
was
not
material.